2022 Annual Meeting | C54 - Vascular Dementia

��ɫ��

2022 Annual Meeting | C54 - Vascular Dementia

Date Sunday 04/03/22

Time 03:30 PM - 05:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Mark R. Etherton, MD

Topic(s) Aging, Dementia, and Behavioral Neurology

Learning Objectives Participants should be able to discuss the diagnostic challenges and current and potential future therapeutic approaches for the management of vascular cognitive impairment and dementia.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist

Teaching Styles Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:35 PM PDT	Introduction	Introduction Mark R. Etherton, MD
03:30 PM - 03:30 PM PDT	Speaker	walk in slides Mark R. Etherton, MD
03:35 PM - 04:05 PM PDT	Speaker	Vascular Cognitive Impairment and Dementia: Clinical Impact and Current Challenges Mark R. Etherton, MD
04:05 PM - 04:10 PM PDT	Q&A	Questions and Answers Mark R. Etherton, MD
04:10 PM - 04:45 PM PDT	Speaker	Diagnosis and Treatment of Vascular Dementia Alessandro Biffi, MD
04:45 PM - 04:50 PM PDT	Q&A	Questions and Answers Alessandro Biffi, MD
04:50 PM - 05:20 PM PDT	Speaker	Cardiovascular Determinants of Brain Aging and Dementia Angela L. Jefferson, PhD
05:20 PM - 05:30 PM PDT	Q&A	Questions and Answers Angela L. Jefferson, PhD

Faculty Disclosures
Mark R. Etherton, MD	Dr. Etherton has received personal compensation for serving as an employee of Takeda Pharmaceutical Company. Dr. Etherton has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Argenica Therapeutics.
Alessandro Biffi, MD	Dr. Biffi has received personal compensation for serving as an employee of Eli Lilly And Company. Dr. Biffi has stock in Eli Lilly And Company.
Angela L. Jefferson, PhD	Dr. Jefferson has received research support from NIH. Dr. Jefferson has received personal compensation in the range of $500-$4,999 for serving as a Observational Safety Monitoring Board Chair and Member with NIH.

��ɫ����

��ɫ����

��ɫ��

��ɫ��